These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1110622)

  • 1. [Therapy of parkinsonism using L-Dopa (Brocadopa)].
    Jörg J
    Med Welt; 1975 Jan; 26(3):124-6. PubMed ID: 1110622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the preparation L-dopa in parkinsonism].
    Proniv DI; Sirotina OS; Bukhovtsev PP; Mis'kiv IaI
    Vrach Delo; 1976 Jan; (1):113-6. PubMed ID: 1246837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and psychometric observations on the use of S-adenosylmethionine in parkinsonism during chronic L-dopa treatment].
    Megna G; Pennetta R; Andreula C
    Acta Neurol (Napoli); 1977; 32(2):204-17. PubMed ID: 930659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of L-dopa treatment of parkinsonism].
    Barbeau A
    Union Med Can; 1975 Jan; 104(1):32-8. PubMed ID: 1111195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of L-dopa treatment in parkinsonism (author's transl)].
    Kolasa M; Reichowa J; Bieniowa A
    Przegl Lek; 1976; 33(3):407-10. PubMed ID: 1273335
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences in the treatment of Parkinsonism using a combination of L-dopa and alpha-methyldopa-hydrazine].
    Vymazal J; Roth B; Nevsímal O
    Cesk Neurol Neurochir; 1976 Mar; 39(2):59-62. PubMed ID: 1260921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years].
    Indo T; Takahashi A
    Rinsho Shinkeigaku; 1987 Nov; 27(11):1419-22. PubMed ID: 3447802
    [No Abstract]   [Full Text] [Related]  

  • 8. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
    Borromei A; Manzini A
    Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmenting procedures during L-dopa therapy for Parkinsonism.
    Bhaskar PA; Bhaskar EA; Jagannathan K
    J Assoc Physicians India; 1975 Jan; 23(1):21-7. PubMed ID: 1194194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined treatment of parkinsonism with L-dopa and Parkopan].
    Lukasiewicz K
    Wiad Lek; 1977 May; 30(10):775-7. PubMed ID: 867994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile parkinsonism. 18 cases].
    Ferreiro JL; Pugliese MI; Caride AE
    Medicina (B Aires); 1991; 51(3):204-8. PubMed ID: 1821902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1978 Sep; 56(9):113-5. PubMed ID: 703225
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].
    Holmsen R
    Tidsskr Nor Laegeforen; 1976 Feb; 96(4):225, 234-6. PubMed ID: 1251394
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602).
    Chouza C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1974; 20(1-4):116-38. PubMed ID: 4619960
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levodopa and controlled release benserazide in the handling of motor fluctuations in Parkinson's disease].
    Díaz F; Chaná P
    Rev Med Chil; 1991 Sep; 119(9):1022-8. PubMed ID: 1845094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toloxatone, parkinsonism and dopa therapy].
    Cantagrel A; Dordain G; Dostert P
    Therapie; 1986; 41(6):493-7. PubMed ID: 3810545
    [No Abstract]   [Full Text] [Related]  

  • 20. The sixth year after L-dopa: quality of life and insights derived.
    Boshes B; Arbit J; Dolkart M; Blonsky ER; Kovach JW
    Trans Am Neurol Assoc; 1975; 100():166-8. PubMed ID: 1226599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.